Four new biosimilars will begin to be sold in Spain in 2025
The biosimilar portfolio will continue to grow in 2025 and At least four generic biologics will enter the market. These ...
The biosimilar portfolio will continue to grow in 2025 and At least four generic biologics will enter the market. These ...
On October 1, 2023, the Sandoz pharmaceutical celebrated the start of the listing of its shares on the Swiss SIX ...